AAAAAA

   
Results: 1-2 |
Results: 2
Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma
Authors: Carella, AM Cavaliere, M Lerma, E Ferrara, R Tedeschi, L Romanelli, A Vinci, M Pinotti, G Lambelet, P Loni, C Verdiani, S De Stefano, F Valbonesi, M Corsetti, MT
Citation: Am. Carella et al., Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma, J CL ONCOL, 18(23), 2000, pp. 3918-3924
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian Lymphoma Study Group (GISL)
Authors: Gobbi, PG Ghirardelli, ML Avanzini, P Baldini, L Quarta, G Stelitano, C Broglia, C Loni, C Silingardi, V Ascari, E
Citation: Pg. Gobbi et al., A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian Lymphoma Study Group (GISL), HAEMATOLOG, 85(3), 2000, pp. 263-268
Risultati: 1-2 |